XML 63 R52.htm IDEA: XBRL DOCUMENT v3.25.2
Shareholders' Equity - Restricted Stock (Details) - Restricted Stock Unit - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Vesting period     3 years      
Stock based compensation expense $ 385,838 $ 313,589 $ 771,676 $ 635,158    
Compensation cost not yet recognized $ 2,426,793   $ 2,426,793   $ 3,198,469  
Weighted average period for recognition     1 year 1 month 20 days   1 year 3 months 18 days  
Number outstanding            
Balance non-vested Stock at beginning of period (in shares)     560,970 491,536 491,536  
Granted (in shares)     0   300,052  
Vested (in shares)     (8,639)   (230,618)  
Balance non-vested Stock at end of period (in shares) 552,331   552,331   560,970 491,536
Weighted Average Remaining Life            
Balance non-vested Stock at end of period (in years)     1 year 1 month 9 days   1 year 7 months 9 days 1 year 8 months 26 days
Granted (in years)         1 year 11 months 1 day  
Weighted Average Grant Date Fair Value            
Weighted Average Grant Date Fair Value , beginning of period     $ 5.77 $ 5.59 $ 5.59  
Weighted Average Grant Date Fair Value, Granted     0   5.97  
Weighted Average Grant Date Fair Value, Vested     6.15   5.65  
Weighted Average Grant Date Fair Value, end of period $ 5.77   $ 5.77   $ 5.77 $ 5.59
Board of Directors            
Number outstanding            
Granted (in shares)     0      
Management, Employees, and Board Of Directors            
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]            
Weighted average market price at grant date (in dollars per share)         $ 5.97  
Number outstanding            
Granted (in shares)         300,052